¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Cell Tissue Bank"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
Jurkat cell
Àúı¼¼Æ÷
juvenile cell
À¯¾à¼¼Æ÷
juxtaglomerular cell tumor
Å丮°ç¼¼Æ÷Á¾¾ç, »ç±¸Ã¼¿·¼¼Æ÷Á¾¾ç
Kupffer¡¯s cell
ÄíÆÛ¼¼Æ÷, º°Å«Æ÷½Ä¼¼Æ÷
killer cell
»ìÇØ¼¼Æ÷
Langerhans cell
¶û°Ô¸£Çѽº¼¼Æ÷
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº¼¼Æ÷Á¶Á÷±¸Áõ
large cell acanthoma
Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, ´ë¼¼Æ÷±Ø¼¼Æ÷Á¾
large cell carcinoma
´ë¼¼Æ÷¾ÏÁ¾, Å«¼¼Æ÷¾ÏÁ¾
lepra cell
³ªº´¼¼Æ÷
leukemic cell
¹éÇ÷º´¼¼Æ÷
Leydig cell tumor
¶óÀ̵ðÈ÷¼¼Æ÷Á¾¾ç
light cell
¹àÀº¼¼Æ÷
lipoid cell
ÁöÁú¼¼Æ÷
luteal cell
Ȳ(»ö)ü¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
luteal cell
Ȳü¼¼Æ÷
lymphoid cell
¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ¸ð¾ç¼¼Æ÷
lymphokine-activated killer cell
¸²Æ÷Ä«ÀÎȰ¼º¼¼Æ÷µ¶¼º¼¼Æ÷
lymphopoietic cell
¸²ÇÁ±¸»ý¼º¼¼Æ÷
marrow cell
°ñ¼ö¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mastoid air cell
²ÀÁö¹úÁý
matrix cell
±âÁú¼¼Æ÷, ÅйÙÅÁÁú¼¼Æ÷
memory cell
¸é¿ª±â¾ï¼¼Æ÷
Merkel cell-neurite complex
Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
mesangial cell
Ç÷°ü»çÀ̼¼Æ÷
mesenchymal cell
Áß°£¿±¼¼Æ÷
mesothelial cell
ÁßÇǼ¼Æ÷
microglial cell
¹Ì¼¼¾Æ±³¼¼Æ÷
mitotic cell
ºÐ¿±â¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
heterotrophic cell
Á¾¼Ó¿µ¾ç¼¼Æ÷.
high peroxidase cell
°íÆä·Ï½Ã´Ù¾ÆÁ¦¼¼Æ÷
hilus cell tumor
¹®¼¼Æ÷Á¾
hilus cell ³ª
¹®¼¼Æ÷(Ú¦á¬øà).
hodgkins disease,lacunar cell in
¿°ø¼¼Æ÷
hodgkins disease,reed-sternberg cell in
¸®À̵å-½ºÅ׸¥º£¸£±× ¼¼Æ÷
horny cell
°¢Áú¼¼Æ÷
huma immunodeficiency virus,follicular dendritic cell infection by
¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T-cell lymphotrophic virus
Àΰ£ T¼¼Æ÷ ¸²ÇÁ ¿µ¾ç¼º ¹ÙÀÌ·¯½º
human t-cell leukemia virus
ÀÎü T¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
hybrid cell
ÇÏÀ̺긮µå¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
tissue interactions
Á¶Á÷°£ (ðÚòÄÊà)ÀÇ »óÈ£ÀÛ¿ë (ßÓû»íÂéÄ)
tissue iron
Á¶Á÷ö(ðÚòÄôÑ)
tissue marker
Á¶Á÷Ç¥ÁöÀÚ
tissue maximum ratio, TMR
Á¶Á÷ÃÖ´ë¼±·®ºñ
tissue metabolism
Á¶Á÷´ë»ç(¡ÓÛÞó).
tissue metamorphosis
Á¶Á÷º¯ÅÂ(¡Ü¨÷¾)
tissue of neural crest (mesectoderm)
½Å°æ´É¼±Á¶Á÷ (Áß°£¿Ü¹è¿±)
tissue parasite tests
tissue phase
Á¶Á÷»ó(ðÚòÄßÓ).
tissue plasminogen activation
Á¶Á÷ ÇöóÁî¹Ì°Õ Ȱ¼º
tissue plasminogen activation inhibitor
Á¶Á÷ ÇöóÁî¹Ì³ë°Õ Ȱ¼º ¾ïÁ¦ÀÎÀÚ
tissue plasminogen activator
tissue polypeptide antigen
Á¶Á÷Æú¸®ÆéƼµåÇ׿ø
tissue pressure
Á¶Á÷¾Ð(ðÚòÄäâ)
tissue pressure
Á¶Á÷¾Ð(ðÚòÄäâ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½